Circe Bioscience Licenses Technology to Decarbonize Industry with Microbes Developed at Wyss Institute at Harvard University

Novel gas fermentation approach enables engineered microbes to “eat” greenhouse gases and produce valuable products for multiple uses

On May 15, 2024, the Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Circe, a startup developed at the Institute and spun out of Harvard, has signed a worldwide, exclusive licensing agreement coordinated by Harvard’s Office of Technology Development (OTD) to commercialize a novel bioproduction technology that could significantly reduce the carbon emissions of industries from food to aviation fuel. Circe has raised more than $8 million to date from investors including Regen Ventures, Undeterred Capital, Ponderosa Ventures, Bee Partners, and Elementum Ventures. “One of the great challenges humanity faces is how to maintain global growth and production and decarbonize everything at the same time. Circe is addressing this critical problem by using gas fermentation to manufacture the products and molecules we need in a carbon-negative way,” said Shannon Nangle, PhD, who co-founded Circe along with fellow Wyss member Marika Ziesack, PhD.

Login Or Register To Read Full Story